Defining leukemia stem cells in acute lymphoblastic leukemia
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110301
- Recipient
-
The Children's Hospital Corporation UEI Z1L9F1MM1RY3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,416,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Boston, MA 02115, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The work will advance understanding of a cancer that afflicts both military and civilian populations. The results have potential to improve treatment for all those diagnosed with this form of leukemia.
Quick answers
Who received award W81XWH2110301?
W81XWH2110301 was awarded to The Children's Hospital Corporation by Medical Command (Department of the Army) on September 15, 2021.
How much is award W81XWH2110301 worth?
$1,416,000 has been obligated on W81XWH2110301.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award